These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1582982)

  • 1. Immunoregulation of murine and human myeloma.
    Hoover RG; Kornbluth J
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):407-24. PubMed ID: 1582982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 beta).
    Raychaudhuri S; Saeki Y; Chen JJ; Iribe H; Fuji H; Kohler H
    J Immunol; 1987 Jul; 139(1):271-8. PubMed ID: 2953815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells.
    Märten A; Renoth S; von Lilienfeld-Toal M; Buttgereit P; Schakowski F; Glasmacher A; Sauerbruch T; Schmidt-Wolf IG
    Haematologica; 2001 Oct; 86(10):1029-37. PubMed ID: 11602408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light chain myeloma plasma cells induce a strong cell-mediated immune response mainly directed against the monoclonal light chain determinants in a murine experimental model.
    Galea HR; Denizot Y; Cogné M
    Cancer Immunol Immunother; 2002 Jun; 51(4):229-34. PubMed ID: 12012110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
    Dembic Z; Schenck K; Bogen B
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma.
    Weiner GJ; Hillstrom JR
    J Immunol; 1991 Dec; 147(11):4035-44. PubMed ID: 1834746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
    Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R
    J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
    Corthay A; Lundin KU; Munthe LA; Frøyland M; Gedde-Dahl T; Dembic Z; Bogen B
    Cancer Immunol Immunother; 2004 Sep; 53(9):759-69. PubMed ID: 15088126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific idiotype vaccines. III. Induction of T helper cells by anti-idiotype and tumor cells.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Sep; 139(6):2096-102. PubMed ID: 2442262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Mannoji M; Namba M
    Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
    Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
    Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
    J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific B cell tumors of mice.
    Bishop GA; Arnold LW; Haughton G
    Crit Rev Immunol; 1986; 6(2):105-21. PubMed ID: 3524998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
    Neelapu SS; Munshi NC; Jagannath S; Watson TM; Pennington R; Reynolds C; Barlogie B; Kwak LW
    Bone Marrow Transplant; 2005 Aug; 36(4):315-23. PubMed ID: 15968284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.